Cell Signaling Technology

Na,K-ATPase Antibody

#3010 · $317

63

Evidence Score · Well-Established

Used by 97 independent labs across 100 papers. How we score this →

100

Citing papers

18.4k

Combined citations

Supplier page Find this product

Research areas

Immune cells in cancer7 Genomics, phytochemicals, and oxidative stress7 Immunotherapy and Immune Responses6 PI3K/AKT/mTOR signaling in cancer6 HER2/EGFR in Cancer Research5 Adipose Tissue and Metabolism5 Extracellular vesicles in disease5 Immune Response and Inflammation5

Papers citing this product

1

Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription

Nature Communications·2016·1.8k cit.·DOI

2

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

Blood·2009·641 cit.·DOI

3

Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization

Journal of Neuroinflammation·2020·609 cit.·DOI

4

Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells

Nature Communications·2018·558 cit.·DOI

5

Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib

JNCI Journal of the National Cancer Institute·2005·467 cit.·DOI

6

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor <i>BRAF</i> gene mutations but lack mutations in <i>KRAS, NRAS,</i> or <i>MEK1</i>

Proceedings of the National Academy of Sciences·2012·436 cit.·DOI

7

Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism

Journal of Clinical Investigation·2006·436 cit.·DOI

8

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Nature·2018·415 cit.·DOI

9

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

Nature Communications·2017·409 cit.·DOI

10

Inhibition of Activator Protein-1, NF-κB, and MAPKs and Induction of Phase 2 Detoxifying Enzyme Activity by Chlorogenic Acid

Journal of Biological Chemistry·2005·388 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.